FUTURE AUROBINDO PHARMA Fundamental Report

SHARE PRICE

Get to know the company overview of AUROPHARMA - face value, book value, exchange symbol, 1 year & lifetime highs/lows, average volume, market cap, PE ratio, 1 month return, % promoter holding pledged before investing in AUROPHARMA

Current Price (Rs.) 680.65
Face Value (Rs.) 1
Book Value (Rs.) 199.39
52 Week High (Rs.) 830.45 (04-Dec-18)
52 Week Low (Rs.) 527.00 (04-Jun-18)
Life Time high (Rs.) 895.00 (06-Oct-16)
Life Time low (Rs.) 0.59 (24-Sep-96)
Exchange Symbol AUROPHARMA (NSE)
Average Daily Movement [ADM] 22.50
Average Volume [20 days](No. of shares) 3106099
Market Cap (Rs. in Cr) 45117.82 (Cr)
1 Month Return (%) 4.86
P/E Ratio (x) 20.61
% of Promoter holding pledged 2.30

SHARE PRICE CHART

We recommend to use only Weekly and Monthly charts. Daily charts are also given which are used for exits.

We do not recommend daily/intraday minute hourly charts.

Why should you follow Weekly & Monthly levels - The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit booking.

AUROBINDO PHARMA, NSE, INDIA

FUTURE AUROBINDO PHARMA, NSE, INDIA

 

QUARTERLY RESULTS

Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17
Quarterly Quarterly Quarterly Quarterly Quarterly Quarterly
Source Of Info (AR = Annual Report, PR = Press Release)
Net Sales/Income from operations
Other Operating Income
Total Income From Operations
Increase/Decrease in Stocks
Consumption of Raw Materials
Purchase of Traded Goods
Employees Cost
Depreciation
Other Expenses
Total Expenditure
Operating Profit
Other Income
P/L Before Int., Excpt. Items & Tax
Interest
P/L Before Exceptional Items & Tax
Exceptional Item
P/L Before Tax
Tax
P/L After Tax from Ordinary Activities
PAT
Minority Interest
Share Of P/L Of Associates
Net Profit/(Loss) For the Period
Equity Share Capital
Reserves
Equity Dividend Rate (%)
EPS (Rs.) [After Extraordinary items]
EPS (Rs.) [Before Extraordinary items]
 

RATIO ANALYSIS

Among all the ratios these are the most important ratios to look before investing in a company.
Get the latest key Financial Ratios and the Ratio Analysis of to gauge the overall financial health of a company before investing.

Name Ratio Good/Not Good Description
Current Ratio (x) 2.57 > 2 is Good,
< 2 is Not Good
A liquidity ratio that measures a companys ability to pay short-term obligations. The higher the current ratio, the more capable the company is of paying its obligations.
Quick Ratio (x) 1.35 > 1 is Good,
< 1 is Not Good
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets
Dividend Yield (%) 0.32 > 1.5 is Good,
< 1.5 is Not Good
A financial ratio that shows how much a company pays out in dividends each year relative to its share price. Dividend yield is calculated as annual dividends per share divided by market price per share.
Interest Coverage Ratio (x) 49.84 > 2 is Good,
< 2 is Not Good
(For Banks & NBFC this is not Valid)
It is used to determine how easily a company can pay interest on outstanding debt. It is calculated by dividing a companys EBIT by the interest expenses.
Debt Equity Ratio (x) 0.38 < 2 is Good,
> 2 is Not Good
(For Banks & NBFC this is not Valid)
A measure of a companys financial leverage calculated by dividing its total liabilities by stockholders equity. The debt/equity ratio also depends on the industry in which the company operates.
Return On Asset (%) 13.65 > 5% is Good,
< 5% is Not Good
An indicator of how efficient management is at using its assets to generate earnings. Calculated by dividing a companys annual earnings by its total assets
Return On Equity (%) 20.74 > 18% is Good,
< 18% is Not Good
Also called Return on networth, it measures a companys profitability by revealing how much profit a company generates with the money shareholders have invested, it is calculated by dividing the net profit after tax by shareholder's fund For high growth companies you should expect a higher ROE.

For investors interested in FUTURE AUROBINDO PHARMA find all important information on FUTURE AUROBINDO PHARMA share price, peer comparison and analysis.

 

DIVIDEND

 

Get a glimpse into the dividend history-payout amount of AUROPHARMA, interim dividend and the latest dividend announcements by AUROPHARMA in the last 5 years.

# Announcement Date Ex-Date Amount Interim/Final
1 08-Feb-2019 15-Feb-2019 1.25 Interim
2 12-Nov-2018 20-Nov-2018 1.25 Interim
3 07-Feb-2018 20-Feb-2018 1.00 Interim
4 09-Nov-2017 21-Nov-2017 1.50 Interim
5 29-May-2017 08-Jun-2017 1.25 Interim
6 15-Nov-2016 24-Nov-2016 1.25 Interim
7 31-May-2016 09-Jun-2016 0.70 Interim
8 09-Feb-2016 18-Feb-2016 0.70 Interim
9 09-Nov-2015 19-Nov-2015 0.60 Interim
10 12-Aug-2015 21-Aug-2015 0.50 Interim
11 28-May-2015 08-Jun-2015 1.00 Interim
12 05-Feb-2015 16-Feb-2015 2.00 Interim
13 05-Aug-2014 13-Aug-2014 1.50 Interim
14 02-Jun-2014 11-Jun-2014 1.75 Interim
15 08-Nov-2013 19-Nov-2013 1.25 Interim
16 31-May-2013 30-Jul-2013 0.50 Final
17 07-Feb-2013 18-Feb-2013 1.00 Interim
18 29-May-2012 30-Jul-2012 1.00 Final
19 09-May-2011 20-Jul-2011 1.00 Final
20 29-Oct-2010 11-Nov-2010 5.00 Interim
21 31-May-2010 13-Sep-2010 2.00 Final
22 27-Jan-2010 05-Feb-2010 3.00 Interim
23 12-Nov-2009 16-Dec-2009 1.50 Final
 

PROMOTER SHAREHOLDING

Look up all relevant information on shareholding pattern of AUROPHARMA, the change in shareholding as compared to last quarter, Promoters shareholding%, persons holding more than 1% shares of the company.

Shareholding PatternMar-19Dec-18Sep-18Jun-18Mar-18
Promoter and Promoter Group (%)51.8751.8751.8751.8751.87
Indian48.8048.8048.8048.8048.80
Foreign3.073.073.073.073.07
Institutions (%)35.1634.5134.1533.6033.63
FII21.4720.0719.1117.7717.99
DII13.6914.4415.0415.8215.63
NonInstitutions (%)12.9713.6213.9814.5314.50
Bodies CorporateNILNILNILNILNIL
Others12.9713.6213.9814.5314.50
CustodiansNILNILNILNILNIL
Total no. of shares (cr.)58.5958.5958.5958.5958.59
 

PUBLIC SHAREHOLDING

Study of the shareholding pattern of a company is a very important part of fundamental analysis. The shareholding pattern is a determinant of the market capitalization of the stock and is an indicator of whether the stock valuation is justified or not. Know the Public shareholding % for the last quarter as announced by the company.

Persons holding securities more than 1% of total number of shares under category Public Shareholding.CategoryDec-16Sep-16Jun-16Mar-16Mar-17
RPR SONS ADVISORS PVT.LTD. , MRS.P.SUNEELA RANI (JOINTLY HOLDING)PromotersNILNILNILNIL33.52
K NITYANANDA REDDYPromoters4.334.704.70NIL4.33
HDFC TRUSTEE COMPANY LIMITED A/C HDFC GROWTH FUNDNonPromoters3.99NILNILNIL4.26
KAMBAM KIRTHI REDDYPromoters3.543.54NILNIL3.53
Bodies CorporateNonPromoters2.872.432.50NIL3.24
VENKATA RAMPRASAD REDDY PENAKAPromoters3.083.083.083.083.07
AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD (JOINTLY HOLDING)PromotersNILNILNILNIL2.85
M SIVAKUMARANPromoters2.512.512.51NIL2.47
SBI ARBITRAGE OPPORTUNITIES FUNDNonPromoters2.301.371.15NIL2.45
RELIANCE CAPITAL TRUSTEE COMPANY LIMITED A/C RELIANCE VISION FUND.NonPromotersNILNILNILNIL1.71
BIRLA SUN LIFE TRUSTEE COMPANY PRIVATE LIMITED AC BIRLA SUN LIFE BALANCED 95 FUNDNonPromoters1.31NILNILNIL1.43
KAMBAM SPOORTHIPromoters1.301.301.301.301.30
STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOLNonPromoters1.09NILNILNIL1.10
JHUNJHUNWALA RAKESH RADHESHYAMNonPromotersNIL1.12NILNIL1.08
ABU DHABI INVESTMENT AUTHORITY - BEHAVENonPromoters1.311.39NIL1.581.02
PENAKA SUNEELA RANIPromoters33.5635.04NILNILNIL
TRIDENT CHEMPHAR LIMITEDPromoters2.082.08NIL2.08NIL
RAKESH JHUNJHUNWALANonPromoters1.09NILNILNILNIL
HDFC TRUSTEE COMPANY LIMITED-HDFC EQUITY FUNDNonPromotersNIL3.623.87NILNIL
STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY PNonPromotersNIL1.25NIL1.27NIL
P SUNEELA RANIPromotersNILNIL35.0435.04NIL
 

COMPANY PROFILE

Study AUROPHARMA management, company profile, ownership, management, Board of Directors and Organization Structure of AUROPHARMA

COMPANY PROFILE OF FUTURE AUROBINDO PHARMA, NSE, INDIA
Date of Incorporation 26-Dec-1986
Date of Listing 19-Oct-1995
Management
NameDesignation
N Govindarajan Managing Director
Rangaswamy Rathakrishnan Iyer Non Exe. & Ind. Director
M Sitarama Murthy Non Exe. & Ind. Director
Avnit Bimal Singh Non Exe. & Ind. Director
K Ragunathan Non Executive Chairman
P V Ramprasad Reddy Non Executive Director
K Nithyananda Reddy Vice Chairman & Whole Time Dir
M Madan Mohan Reddy Whole Time Director
P Sarath Chandra Reddy Whole Time Director
M Sivakumaran Whole Time Director
Registered Office Address
Plot No.2, Maitri Vihar, Ameerpet,, 500038, Hyderabad, Telangana, India,
Website
http://www.aurobindo.com
 

PEERS PRICE COMPARISION

# Company Name Open High Low Last Price Prv Price Change % Chng
1 AUROBINDO PHARMA 761.70 772.00 753.50 764.45 764.45 0 0.00
2 MERCK 1015.50 1072.00 1015.50 1064.30 1064.30 0 0.00
3 MARKSANS PHARMA 45.50 46.20 44.75 45.25 45.25 0 0.00
4 SHILPA MEDICARE 659.50 663.90 645.25 656.85 656.85 0 0.00
5 SYNGENE 495.10 503.65 491.00 493.95 493.95 0 0.00
6 IPCA 500.00 503.45 493.00 495.55 495.55 0 0.00
7 OPTO CIRCUITS 6.95 7.00 6.90 6.95 6.95 0 0.00
8 ALEMBIC PHARMA 500.00 501.70 497.00 500.30 500.30 0 0.00
9 KOPRAN 71.30 72.00 70.50 70.90 70.90 0 0.00
10 RPG LIFE 387.55 405.00 387.55 396.80 396.80 0 0.00
11 CAPLIN POINT 700.40 707.50 690.20 697.90 697.90 0 0.00
12 FDC 183.10 188.10 183.10 186.75 186.75 0 0.00
13 NECTAR LIFESCIENCES 27.65 27.65 26.95 27.20 27.20 0 0.00
14 SPARC 370.40 374.80 365.50 367.85 367.85 0 0.00
15 VIMTA LABS 128.40 130.40 128.40 129.00 129.00 0 0.00
16 JB CHEMICALS 280.25 283.15 275.00 275.90 275.90 0 0.00
17 PFIZER 1728.80 1730.05 1711.00 1717.15 1717.15 0 0.00
18 BROOKS LAB 107.00 112.50 107.00 108.80 108.80 0 0.00
19 MOREPEN LAB 16.75 17.00 16.50 16.60 16.60 0 0.00
20 SANOFI INDIA 4208.95 4230.00 4200.00 4213.30 4213.30 0 0.00
21 DISHMAN 288.20 304.20 278.00 301.20 301.20 0 0.00
22 SUVEN 222.05 230.40 218.10 221.15 221.15 0 0.00
23 GLAXO PHARMA 2464.00 2474.00 2436.30 2451.80 2451.80 0 0.00
24 NATCO PHARMA 995.95 995.95 983.00 986.70 986.70 0 0.00
25 ALKEM LABORATORIES 1841.00 1843.00 1821.00 1825.00 1825.00 0 0.00
26 VENUS REMEDIES 104.05 104.15 103.00 103.50 103.50 0 0.00
27 JUBILANT 657.60 662.85 641.60 643.70 643.70 0 0.00
28 PIRAMAL ENTERPRISES 2746.00 2774.90 2725.25 2761.50 2761.50 0 0.00
29 BLISS GVS 175.00 178.90 168.60 176.85 176.85 0 0.00

CIN: U67190WB2003PTC096617. Trading in Commodities is done through our Group Company Dynamic Commodities Pvt. Ltd. The company is also engaged in Proprietory Trading apart from Client Business.
“2019 © COPYRIGHT DYNAMIC EQUITIES PVT. LTD.”

Disclaimer: There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Disclosure: We, Dynamic Equities Private Limited are also engaged in Proprietory Trading apart from Client Business. In case of any complaints/grievances, clients may write to us at compliance@dynamiclevels.com

  • Download our Mobile App
  • Available on Google Play
  • Available on App Store
  • RSS